Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Tomsk Switching Company approved dividends for 2023

6/18/24 TORS

Shareholders of Rosseti Kuban approved dividends for 2023

6/18/24 KUBE

Mostotrest wins tender for construction of a bypass around a monastery in Crimea

6/18/24 MSTT

Sitronics wants to digitize rivers and seas

6/18/24 AFKS

Ozon created a leasing company

6/18/24 OZON

Magnit Market came to Moscow

6/17/24 MGNT

Shareholders of Korshynov Mining Plant approved dividends for 2023

6/17/24 KOGK

OGK-2 launched a modernized turbine unit at Kirishskaya GRES

6/17/24 OGKB

Metacraft has raised the minimum amount of success

6/17/24 OTCI

Delimobil returns to the Bashkiria market

6/17/24 DELI